ITI Pharma and Healthcare Fund - Regular Plan - Growth Option
₹16.4949
₹0.19 (-1.14%)
NAV as of 29 May 2026
Today's NAV — all variants
Regular · Growth
₹₹16.4949
₹0.19 (-1.14%)
29 May 2026
AMFI: 149270
Direct · Growth
₹₹18.0712
₹0.21 (-1.13%)
29 May 2026
AMFI: 149268
Regular · IDCW
₹₹16.4949
₹0.19 (-1.14%)
29 May 2026
AMFI: 149269
Direct · IDCW
₹₹18.0692
₹0.21 (-1.13%)
29 May 2026
AMFI: 149271
Returns (Lumpsum)
CAGR for periods ≥ 1 yearSIP Returns (XIRR)
₹1,000/month SIP, annualisedSIP since inception — what ₹500/month became
Real NAV backtest from day one
₹27,000
Invested
₹36,997
Value today
14.0%
XIRR (p.a.)
₹500/month SIP from fund inception · Current value as of today
Try SIP Calculator with this fund's history₹1,000 lumpsum at launch — value today
Invested on the fund's first NAV date
₹1,000
Invested
₹1,649
Value today
11.6%
CAGR (p.a.)
One-time investment at fund inception · Growth purely from NAV appreciation
Try Lumpsum Calculator₹6L corpus via 12-month STP from a liquid fund at inception
₹50K/month transferred from HDFC Liquid → this fund at launch
₹6,00,000
Invested
₹10,69,566
Value today
+8.1%
vs lumpsum
STP beat direct lumpsum by 8.1% — reduced timing risk paid off
Model your own STP with real NAVBeat the benchmark — ₹500/month SIP
Same SIP in this fund vs the benchmark index
This fund
₹36,997
Benchmark
₹33,953
+₹3,044 extra wealth vs the benchmark index
Backtest this SIP yourselfDirect vs Regular — ₹500/month over 4 years
Expense ratio drag on your actual returns
Direct plan
₹34,238
Regular plan
₹32,735
Direct earns ₹1,503 more on a ₹24K investment — 1.57% extra return per year
Same fund, same NAV history — only the expense ratio differs. Direct plans always outperform Regular over time.
Learn about Direct vs Regular plansFund Details
Risk Metrics
Trailing 1 year, annualised-0.36
Sharpe Ratio
-0.04
Alpha
0.36
Beta
-0.33
Sortino
15.67%
Std Dev
-17.64%
Max Drawdown
Portfolio Holdings
Performance Comparison
Interested in This Fund?
Our experts will help you decide if this fund fits your goals.
Compare with Similar Funds
Investment Objective
ITI Pharma and Healthcare Fund - Regular Plan - Growth Option invests in stocks from a specific sector or theme, offering concentrated exposure to a particular area of the economy. These funds carry sector-specific risks but can deliver significant returns when the underlying sector performs well.
About This Fund
ITI Pharma and Healthcare Fund - Regular Plan - Growth Option is a Sectoral / Thematic mutual fund offered by ITI Mutual Fund. The fund has been operational for over 4 years. It manages assets worth ₹217 Cr, reflecting investor confidence in the fund's strategy. It benchmarks its performance against NIFTY 500 TRI. The current expense ratio is 2.35%.
Who Should Invest?
- •Investors with a high risk appetite seeking long-term wealth creation
- •Investors with an investment horizon of 5 years or more
- •SIP investors who can benefit from rupee cost averaging during market fluctuations